Highlights of the San Antonio Breast Cancer Symposium 2016: Part 2

John R. Benson; Ismail Jatoi

doi:10.2217/fon-2017-0089

Highlights of the San Antonio Breast Cancer Symposium 2016: Part 2

John R. Benson, Ismail Jatoi

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

The 39th annual San Antonio Breast Cancer Symposium (SABCS) was convened in San Antonio, Texas, on 9-13 December 2016. More than 7000 clinicians and scientists from around the world participated in the symposium which featured a range of presentations and keynote talks pertaining to breast cancer screening, prevention, locoregional and systemic therapies. This two-part report highlights a selection of important studies presented at this premier breast cancer event with Part 1 focusing onmetastatic breast cancer, extended endocrine therapy and the prognostic significance of BRCA1/2 gene mutations. The second part of this report will discuss a range of topics including anti-HER2 directed treatments, the impact of radiotherapy on implant and autologous flap based reconstruction, biological risk predictors for ductal carcinoma-in situ (DCIS), longer term effects of dietary fat modification and the influence of aromatase inhibitors on endothelial cell function.

Original language	English (US)
Article number	0089
Journal	Future Oncology
Volume	13
Issue number	16
DOIs	https://doi.org/10.2217/fon-2017-0089
State	Published - Jul 2017

Keywords

San Antonio
breast conserving surgery
extended endocrine therapy
mastectomy
radiation treatment
reconstruction

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.2217/fon-2017-0089

Cite this

@article{5a650d202f77452f9f6c7a61f868b86e,

title = "Highlights of the San Antonio Breast Cancer Symposium 2016: Part 2",

abstract = "The 39th annual San Antonio Breast Cancer Symposium (SABCS) was convened in San Antonio, Texas, on 9-13 December 2016. More than 7000 clinicians and scientists from around the world participated in the symposium which featured a range of presentations and keynote talks pertaining to breast cancer screening, prevention, locoregional and systemic therapies. This two-part report highlights a selection of important studies presented at this premier breast cancer event with Part 1 focusing onmetastatic breast cancer, extended endocrine therapy and the prognostic significance of BRCA1/2 gene mutations. The second part of this report will discuss a range of topics including anti-HER2 directed treatments, the impact of radiotherapy on implant and autologous flap based reconstruction, biological risk predictors for ductal carcinoma-in situ (DCIS), longer term effects of dietary fat modification and the influence of aromatase inhibitors on endothelial cell function.",

keywords = "San Antonio, breast conserving surgery, extended endocrine therapy, mastectomy, radiation treatment, reconstruction",

author = "Benson, {John R.} and Ismail Jatoi",

note = "Publisher Copyright: {\textcopyright} 2017 Future Medicine Ltd.",

year = "2017",

month = jul,

doi = "10.2217/fon-2017-0089",

language = "English (US)",

volume = "13",

journal = "Future Oncology",

issn = "1479-6694",

publisher = "Taylor and Francis Ltd.",

number = "16",

}

TY - JOUR

T1 - Highlights of the San Antonio Breast Cancer Symposium 2016

T2 - Part 2

AU - Benson, John R.

AU - Jatoi, Ismail

PY - 2017/7

Y1 - 2017/7

N2 - The 39th annual San Antonio Breast Cancer Symposium (SABCS) was convened in San Antonio, Texas, on 9-13 December 2016. More than 7000 clinicians and scientists from around the world participated in the symposium which featured a range of presentations and keynote talks pertaining to breast cancer screening, prevention, locoregional and systemic therapies. This two-part report highlights a selection of important studies presented at this premier breast cancer event with Part 1 focusing onmetastatic breast cancer, extended endocrine therapy and the prognostic significance of BRCA1/2 gene mutations. The second part of this report will discuss a range of topics including anti-HER2 directed treatments, the impact of radiotherapy on implant and autologous flap based reconstruction, biological risk predictors for ductal carcinoma-in situ (DCIS), longer term effects of dietary fat modification and the influence of aromatase inhibitors on endothelial cell function.

AB - The 39th annual San Antonio Breast Cancer Symposium (SABCS) was convened in San Antonio, Texas, on 9-13 December 2016. More than 7000 clinicians and scientists from around the world participated in the symposium which featured a range of presentations and keynote talks pertaining to breast cancer screening, prevention, locoregional and systemic therapies. This two-part report highlights a selection of important studies presented at this premier breast cancer event with Part 1 focusing onmetastatic breast cancer, extended endocrine therapy and the prognostic significance of BRCA1/2 gene mutations. The second part of this report will discuss a range of topics including anti-HER2 directed treatments, the impact of radiotherapy on implant and autologous flap based reconstruction, biological risk predictors for ductal carcinoma-in situ (DCIS), longer term effects of dietary fat modification and the influence of aromatase inhibitors on endothelial cell function.

KW - San Antonio

KW - breast conserving surgery

KW - extended endocrine therapy

KW - mastectomy

KW - radiation treatment

KW - reconstruction

UR - http://www.scopus.com/inward/record.url?scp=85026902667&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026902667&partnerID=8YFLogxK

U2 - 10.2217/fon-2017-0089

DO - 10.2217/fon-2017-0089

M3 - Article

C2 - 28685613

AN - SCOPUS:85026902667

SN - 1479-6694

VL - 13

JO - Future Oncology

JF - Future Oncology

IS - 16

M1 - 0089

ER -

Highlights of the San Antonio Breast Cancer Symposium 2016: Part 2

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this